Open AccessP350: BLINATUMOMAB AND DONOR LYMPHOCYTE INFUSION (DLI) FOR MOLECULAR RELAPSE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC PATIENTS
Author(s) -
Muriano F.,
Cacace F.,
Caprioli V.,
D'amico M. R.,
De Simone G.,
Giagnuolo G.,
Menna G.,
Tambaro F. P.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844288.52565.46
Subject(s) - blinatumomab , medicine , hematopoietic stem cell transplantation , donor lymphocyte infusion , salvage therapy , oncology , minimal residual disease , chemotherapy , refractory (planetary science) , transplantation , leukemia , lymphoblastic leukemia , physics , astrobiology